Valvular & structural heart disease

Transcatheter Edge-to-Edge Repair in Patients With Complex Tricuspid Valve Anatomy

JACC Cardiovasc IntervPublished Single-arm cohort of the TRILUMINATE Pivotal trial

Authors' conclusion

In patients with complex tricuspid anatomies, TEER with the TriClip system demonstrated excellent procedural safety with significant TR reduction and associated improvements in quality of life at 1 year.

Study context

Population
Patients with severe tricuspid regurgitation (TR) and complex tricuspid valve anatomy (excluded from the randomized arm)primary analysis population
Participants
100 patients
Outcome
Survival with KCCQ score improvement ≥10 points
Follow-up
1 year
Methodological detailsmulticenter, international, performance goal
  • Multicenter
  • International
  • Performance goal

Main finding

As reported in the abstract

1-year survival with KCCQ score improvement ≥10 points

Primary endpoint met (outcome)

46.2%

Performance goal

30%

P value vs performance goal

P = 0.0008

Observational data: associations, not effects.

Further findings

Moderate or less TR · 1 year

Subjects with moderate or less TR
81%

All-cause mortality and HF hospitalization · 1 year

All-cause mortality
15%
HF hospitalization
24%

NYHA functional class and KCCQ overall scores · 1 year

Significant improvements, maintained at 1 year

Safety

Major adverse events or deaths · 30 days postprocedure

No major adverse events or deaths

Original publication

Transcatheter Edge-to-Edge Repair in Patients With Complex Tricuspid Valve Anatomy. JACC Cardiovasc Interv. Published 9 December 2024. doi:10.1016/j.jcin.2024.08.035

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.